We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 9,961 results
  1. Getting the Price Right: Lessons for Medicare Price Negotiation from Peer Countries

    The USA pays more for brand-name prescription drugs than any other country and new legislation from August 2022 gives Medicare the authority to...

    Leah Z. Rand, Aaron S. Kesselheim in PharmacoEconomics
    Article 09 November 2022
  2. Uncovering the interhospital price variations for vasectomies in the United States

    Due to the historic lack of transparency in healthcare pricing in the United States, the degree of price variation for vasectomy is largely unknown....

    Sherry Mortach, Nicholas Sellke, ... Nannan Thirumavalavan in International Journal of Impotence Research
    Article Open access 22 February 2024
  3. Assessing the price levels of medical service and influential factors: evidence from China

    Background

    Medical service prices play a crucial role in cost containment in China. This study aimed to assess the change in medical service price...

    Yanxian Lin, Luo Li, Bao Liu in BMC Public Health
    Article Open access 08 January 2024
  4. Examining confidential wholesale margin estimates in European countries for the price negotiation of patented drugs in Germany: a statistical model

    Background

    Based on the legal framework laid down in section 130b (9) of Book V of the German Social Code, various criteria are relevant for the...

    Iris an der Heiden, Guido Schiffhorst, ... Stefanie Wiberny in Health Economics Review
    Article Open access 12 April 2024
  5. Is the price right? Paying for value today to get more value tomorrow

    Background

    Contemporary debates about drug pricing feature several widely held misconceptions, including the relationship between incentives and...

    Sreeram V. Ramagopalan, Jose Diaz, ... Peter Kolchinsky in BMC Medicine
    Article Open access 30 January 2024
  6. Price setting in the Brazilian private health insurance sector

    Brazil’s private health insurance market is the second largest in the world, behind only the United States, making it a valuable source of real-world...

    Mônica Viegas Andrade, Carolina Marinho, ... Flavia Colares in International Journal of Health Economics and Management
    Article 10 September 2023
  7. Food industry perspectives on potential policies targeting unhealthy food and beverage price promotions in Australian supermarkets

    Current supermarket price promotions are likely to encourage unhealthy diets, leading some governments to recently endorse restrictions on price...

    Lily Grigsby-Duffy, Adrian J Cameron, ... Gary Sacks in BMC Public Health
    Article Open access 26 July 2022
  8. The vacated space of volume/price of the drugs centralized procurement with quantity in secondary and above public hospitals of China

    Background

    In 2018, the National Centralized Drug Procurement (NCDP) policy has been implemented in 11 provinces, and promoted across the country in...

    **gliang Wang, Siyu Zhang, ... Liang Zhu in BMC Health Services Research
    Article Open access 29 June 2024
  9. The impact of hospital price and quality transparency tools on healthcare spending: a systematic review

    Background

    Global spending on health was continuing to rise over the past 20 years. To reduce the growth rates, alleviate information asymmetry, and...

    **yang Chen, Marisa Miraldo in Health Economics Review
    Article Open access 14 December 2022
  10. Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers

    Background

    Federal rules mandate that hospitals publish payer-specific negotiated prices for all services. Little is known about variation in...

    Roshun Sankaran, John O’Connor, ... Hari Nathan in Annals of Surgical Oncology
    Article 20 March 2024
  11. Effectiveness of Emotion-Regulation Interventions on Substance Misuse and Emotion Regulation Outcomes in Individuals with Substance Dependence: A Systematic Review and Meta-Analysis

    Purpose of Review

    Substance dependence across multiple substances is consistently associated with emotion dysregulation. In the last two decades,...

    Siddhartha Peri, Gopi K. Neppala, ... Muhammad A. Parvaz in Current Addiction Reports
    Article 31 May 2024
  12. Revisiting the Relationship Between Price Regulation and Pharmaceutical R&D Investment

    Background

    A trade-off exists between affordability of pharmaceutical products today and incentives for firms to provide new and better drugs in the...

    Mujaheed Shaikh, Pietro Del Giudice, Dimitrios Kourouklis in Applied Health Economics and Health Policy
    Article Open access 15 July 2020
  13. Factors Associated with Compliance to the Hospital Price Transparency Final Rule: a National Landscape Study

    BACKGROUND

    The Hospital Price Transparency Final Rule, effective January 1, 2021, requires hospitals to post online a machine-readable file that...

    John Xuefeng Jiang, Daniel Polsky, ... Ge Bai in Journal of General Internal Medicine
    Article 13 December 2021
  14. Changes in sugar-sweetened beverage purchases across the price distribution after the implementation of a tax in Mexico: a before-and-after analysis

    Background

    A tax of one-Mexican peso per liter of sugar-sweetened beverage (SSB) came into effect in January 2014 in Mexico as a national health...

    J. C. Salgado Hernández, S. W. Ng, M. A. Colchero in BMC Public Health
    Article Open access 07 February 2023
  15. Health technology assessment and price negotiation alignment for rare disorder drugs in Canada: Who benefits?

    Background

    Since 2014, the Canadian Agency for Drugs and Technologies in Health (CADTH), which performs health technology assessments for all federal,...

    Nigel S. B. Rawson in Orphanet Journal of Rare Diseases
    Article Open access 13 June 2022
  16. The impact of price transparency and competition on hospital costs: a research on all-payer claims databases

    Background

    Public reporting has been considered effective in reducing health care costs by mitigating information asymmetry in the market as payers...

    Ahreum Han, Keon-Hyung Lee, Jongsun Park in BMC Health Services Research
    Article Open access 05 November 2022
  17. E-cigarette Use and Regulation in South Africa: a Synthesis of Evidence in Response to Industry Efforts to Undermine Product Regulation

    Purpose of Review

    This narrative review of the published scientific literature on e-cigarettes in South Africa examines and responds to reports...

    Olalekan Ayo-Yusuf, Lungile Nkosi, Israel Agaku in Current Addiction Reports
    Article 09 November 2022
  18. Differential Gene Regulation of the Human Blastocyst Trophectoderm and Inner Cell Mass by Progesterone

    Knowledge of action of progesterone (P4) on the human preimplantation embryo is lacking. The objective of this study was to determine expression of a...

    Kathryn Shaia Snow, Douglas J. Raburn, Thomas M. Price in Reproductive Sciences
    Article 27 December 2023
Did you find what you were looking for? Share feedback.